Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93. Case and Commentary Dec 2022 How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters? Adam T. Perzynski, PhD and Kurt C. Stange, MD, PhD Patients experiencing homelessness and mental illness face conditions and circumstances that deserve focused ethical and clinical attention. AMA J Ethics. 2022;24(12):E1112-1120. doi: 10.1001/amajethics.2022.1112. Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740. Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702. Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93.
Case and Commentary Dec 2022 How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters? Adam T. Perzynski, PhD and Kurt C. Stange, MD, PhD Patients experiencing homelessness and mental illness face conditions and circumstances that deserve focused ethical and clinical attention. AMA J Ethics. 2022;24(12):E1112-1120. doi: 10.1001/amajethics.2022.1112.
Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740.
Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702.
Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471.